Nucleic Acid Construct Encoding Chimeric Rhodopsin - Restore Vision
Summary
USPTO granted Patent US12606606B2 to Restore Vision Inc. for a nucleic acid construct encoding a chimeric rhodopsin protein combining ion-transporting receptor rhodopsin with G protein-coupled receptor rhodopsin sequences. The patent contains 17 claims classified under C07K peptide chemistry and covers applications for preventing retinal diseases and enhancing visual function.
What changed
USPTO issued Patent US12606606B2 to Restore Vision Inc., granting exclusive rights to a chimeric rhodopsin nucleic acid construct. The patent covers both the construct composition and methods for preventing and suppressing retinal disease progression while enhancing visual cognitive function.
For competitors in gene therapy, ophthalmic biotechnology, or optogenetic research, this grant signals an existing IP position in chimeric rhodopsin technology for retinal applications. Companies developing similar rhodopsin-based therapies should conduct freedom-to-operate analyses to assess potential infringement exposure.
Archived snapshot
Apr 21, 2026GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.
Nucleic acid construct that encodes chimeric rhodopsin
Grant US12606606B2 Kind: B2 Apr 21, 2026
Assignee
RESTORE VISION INC.
Inventors
Toshihide Kurihara, Yusaku Katada, Kazuo Tsubota, Hideki Kandori
Abstract
Provided are: a nucleic acid including a nucleic acid sequence encoding a chimeric protein including at least part of an ion-transporting receptor rhodopsin and at least part of a G protein-coupled receptor rhodopsin and a nucleic acid sequence encoding a signal sequence; and a nucleic acid including a nucleic acid sequence encoding a chimeric protein including at least part of an ion channeling receptor rhodopsin and at least part of a G protein-coupled receptor rhodopsin; and a nucleic acid construct including the nucleic acid sequences. The use of the nucleic acids or nucleic acid constructs prevents and suppresses the progress of retinal diseases, and enhances the visual cognitive behavioral function and visual function.
CPC Classifications
C07K 2319/00 C07K 2319/43 C07K 19/00 C07K 2319/01 C07K 2319/02 C07K 14/705 C12N 15/63 C12N 15/62 C12N 15/86 C12N 15/861
Filing Date
2020-09-11
Application No.
17642923
Claims
17
Mentioned entities
Related changes
Get daily alerts for USPTO Patent Grants - Peptides (C07K)
Daily digest delivered to your inbox.
Free. Unsubscribe anytime.
Source
About this page
Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission
Source document text, dates, docket IDs, and authority are extracted directly from USPTO.
The summary, classification, recommended actions, deadlines, and penalty information are AI-generated from the original text and may contain errors. Always verify against the source document.
Classification
Who this affects
Taxonomy
Browse Categories
Get alerts for this source
We'll email you when USPTO Patent Grants - Peptides (C07K) publishes new changes.
Subscribed!
Optional. Filters your digest to exactly the updates that matter to you.